20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
TP2207 | Pasireotide Acetate | Somatostatin | |
Pasireotide Acetate is a stable cyclohexapeptide somatostatin mimic | |||
T0081 | Lafutidine | FRG-8813 | 5-HT Receptor , Histamine Receptor |
Lafutidine (FRG-8813) is a newly developed histamine H(2)-receptor antagonist, which can inhibit gastric acid secretion. | |||
T8388 | Vonoprazan | TAK-438 (free base) | Proton pump |
Vonoprazan (TAK-438 (free base)) is an orally active potassium-competitive acid blocker.Vonoprazan can be used for the treatment of gastroduodenal ulcer and reflux esophagitis | |||
T21254 | Vonoprazan Fumarate | TAK-438,TAK 438,Vonoprazan Fumurate,TAK438 | Proton pump |
Vonoprazan Fumarate (TAK438) , a novel potassium-competitive acid blocker, inhibits gastric acid secretion. Vonoprazan Fumarate (TAK438) inhibited H+,K+-ATPase activity in porcine gastric microsomes with IC50 value of 19... | |||
T29015 | Trithiozine | Tresanil,Sulmetozine,Tritiozinum,Tritiozine,Tritiozina | Others |
Trithiozine (Tritiozinum) exhibits antisecretory and antiulcer capacity. Trithiozine can be used for research on the treatment of peptic ulcer disease and hypersecretory disorders. | |||
T15195 | Ebrotidine | FI3542 | Histamine Receptor |
Ebrotidine (FI3542) is a competitive H2-receptor antagonist with Ki of 127.5 nM. Ebrotidine has a potent antisecretory activity and evidenced gastroprotection. | |||
T6710 | Troxipide | Aplace | Others |
Troxipide (Aplace), a new-type systemic non-antisecretory gastric cytoprotective agent, which is mucus-secreting, anti-ulcer, and anti-inflammatory properties irrespective of pH of stomach or duodenum. | |||
T2138 | Oxyphencyclimine Hydrochloride | Spazamin,Daricon,Ulcociclinina | AChR |
Oxyphencyclimine Hydrochloride (Ulcociclinina) is a synthetic tertiary amine and antimuscarinic agent with antispasmodic and antisecretory activities. | |||
T0786 | Clidinium bromide | Ro 2-3773 | AChR |
Clidinium bromide (Ro 2-3773) , a synthetic anticholinergic agent, has been shown in experimental and clinical researchers to have a pronounced antisecretory and antispasmodic effect on the gastrointestinal tract. It can... | |||
T31195 | Dalcotidine | KU 1257,KU-1257 | Histamine Receptor |
Dalcotidine (KU 1257) is a novel histamine H2 receptor antagonist with histamine H9 receptor antagonistic activity and antisecretory effects.The Ki value for binding to guinea pig cerebral cortex was 0.040 The KB value f... | |||
T13382 | Zaltidine | CP-57361 | Others |
Zaltidine is an antagonist of H2-receptor, and has the antisecretory action. | |||
TP2343 | Lagatide | ||
Lagatide is a synthetic heptapeptide that has antisecretory activity. | |||
T71390 | AY 29315 | ||
AY 29315 is a histamine H2-receptor antagonist with antisecretory and antiulcer activities. | |||
T12369 | Pasireotide pamoate | SOM230 pamoate | Others |
Pasireotide pamoate is a stable cyclohexapeptide somatostatin mimic. Pasireotide pamoate exhibits antisecretory, antiproliferative, and proapoptotic activity. | |||
T68133 | Quisultazine | ||
Quisultazine is a phenothiazine derivative with no central effects, can be classified as a non anti H2 antisecretory agent. | |||
T36154 | 15(S)-15-methyl Prostaglandin E2 | 15(S)-15-methyl Prostaglandin E2 | |
15(S)-15-methyl PGE2 is a potent, metabolically stable analog of PGE2. It is a potent gastric antisecretory and antiulcer compound. 15(S)-15-methyl PGE2 binds to human myometrium with twice the affinity of PGE2 and is te... | |||
T70473 | Parapenzolate Free Base | ||
Parapenzolate Free Base is a safe and effective anticholinergic drug possessing antisecretory and antimotility properties and prolonged duration of action. Clinical investigation has shown that after an oral dose of the ... | |||
T27092 | CS-526 | R-105266,R 105266,R105266 | |
CS-526 is a proton pump inhibitor. The inhibitory mechanism of CS-526 on H+,K+-ATPase was a competitive antagonism to the K+ binding site of H+,K+-ATPase, and it was also a reversible inhibition. CS-526 has a potent anti... | |||
T9660 | Bexlosteride | ||
Bexlosteride (LY300502), a benzoquinolinone derivative, functions as a human type I 5α-reductase inhibitor. It demonstrates metabolic inhibition, antiproliferative, and antisecretory activities specifically in LNCaP huma... | |||
T75248 | Pasireotide (diaspartate) | ||
Pasireotide diaspartate (SOM230), a long-acting cyclohexapeptide and somatostatin analog, enhances agonist activity across somatostatin receptor subtypes (sst1/2/3/4/5, with pK i values of 8.2, 9.0, 9.1, <7.0, and 9.9, r... |